Renal-Adjusted Cefuroxime Dosing for UTI
For this 86-year-old female with a CrCl of 30.6 mL/min and uncomplicated UTI, administer cefuroxime 750 mg every 12 hours for 7 days.
Dosing Rationale
The FDA label provides explicit renal dosing guidance for cefuroxime that directly applies to this patient 1. With a creatinine clearance of 30.6 mL/min, this patient falls into the 10-20 mL/min to >20 mL/min range where 750 mg every 12 hours is the recommended dose for renal impairment 1.
Standard vs. Renal-Adjusted Dosing
- Normal renal function (CrCl >20 mL/min): 750 mg every 8 hours for uncomplicated UTI 1
- CrCl 10-20 mL/min: 750 mg every 12 hours 1
- Your patient (CrCl 30.6 mL/min): Falls just above the 10-20 range, but given her age (86 years) and the conservative approach needed in elderly patients with borderline renal function, 750 mg every 12 hours is appropriate
The pharmacokinetic data supports this adjustment: in patients with CrCl 20-59 mL/min, the serum half-life of cefuroxime extends to 2.4 hours (compared to 1.7 hours in normal function), and therapeutic levels remain above 8 mcg/mL for 6 hours 2. This extended half-life justifies the longer dosing interval.
Duration of Therapy
Treat for 7 days minimum. While the 2024 guidelines note insufficient evidence for specific β-lactam duration recommendations in cystitis 3, the FDA label recommends 5-10 days for uncomplicated UTI 1. Given her age and renal impairment (which qualifies as a complicating factor), a 7-day course is prudent.
Critical Caveats
Important Considerations:
- Cefuroxime is NOT first-line for simple cystitis according to 2024 guidelines 3, 4. Preferred agents include nitrofurantoin (5 days), fosfomycin (single dose), or TMP-SMX (3 days) 4
- If this is actually pyelonephritis (fever, flank pain, CVA tenderness), the guidelines recommend 7 days of β-lactam therapy 3, but cefuroxime is not specifically listed in the EAU 2024 recommendations for pyelonephritis 4
- Oral cephalosporins achieve significantly lower blood concentrations than IV 4, which matters if systemic infection is present
When to Use Cefuroxime:
- β-lactamase producing organisms suspected or confirmed
- Patient cannot tolerate first-line agents
- Local resistance patterns favor cephalosporins
- Previous culture showing susceptibility
Monitoring:
- Urine concentrations remain therapeutic (>1,300 mcg/mL) even with renal impairment 1, making cefuroxime effective for UTI despite dose reduction
- Continue for minimum 48-72 hours after symptom resolution 1
- If symptoms persist beyond 72 hours, obtain urine culture and consider alternative diagnosis or resistant organism
Dialysis Consideration:
Though not applicable here (CrCl 30.6), note that patients on hemodialysis require an additional 750 mg dose after each dialysis session 1.
The dose adjustment is critical because cefuroxime is 89% renally excreted 1, and failure to adjust risks drug accumulation and toxicity in this elderly patient with moderate renal impairment.